Alemania: Bayer y Monsanto buscan luz verde para fusión – venderán $2,500 mdd en activos
El gigante petroquímico alemán Bayer, junto con la estadounidense Monsanto, han anunciado la puesta en venta de activos valuados en alrededor de $2,500 millones de dólares, buscando así sortear los obstáculos y dudas de agencias reguladoras que podrían oponerse a la fusión de éstas empresas, en un acuerdo anunciado en $66,000 millones de dólares.
Featured News
ICE’s $6 Billion MarketAxess Takeover Advances After US Antitrust Clearance
Oct 25, 2026 by
CPI
McCormick’s $44.8 Billion Unilever Food Deal Clears Key US Antitrust Hurdle
Oct 25, 2026 by
CPI
EU Launches Antitrust Probe Into Key Paper-Making Material
Oct 25, 2026 by
CPI
UK Seeks Exemption From EU Technology Rules as Trade Tensions Grow
Oct 25, 2026 by
CPI
Live Nation Reveals Trump Attended White House Antitrust Settlement Meeting
Oct 25, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – EU Merger Guidelines
Oct 19, 2026 by
CPI
In Praise of Theories of Benefits
Oct 19, 2026 by
Cyril Hariton & Pierre Regibeau
Closing the Efficiencies Gap
Oct 19, 2026 by
Kasia Czapracka & Marika Harjula
Analysis of Dynamic Trade-Offs Under the New Guidelines: Would Cases Like Amazon/Irobot Turn Out Differently?
Oct 19, 2026 by
Oliver Latham, Sam Marden, Saul Mendelsohn & Serge Moresi
Exploitative Portfolio Effects In EU Merger Control: From Mars/Kellanova to the Draft Merger Guidelines
Oct 19, 2026 by
Niels Baeten, Danette Chan & Elizabeth Malik